Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Dr
Work may provide insights to help improve treatment paradigm for retinal disordersDALLAS--(BUSINESS WIRE)--$CE--Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced an agreement with Johns Hopkins University Department of Ophthalmology to collaborate on a study of susta...
Source: pharmiweb.com